Relapse and / or Refractory Myeloma
1 clinical trials · Condition
◉ Watch Relapse and / or Refractory Myeloma
| Record | Firm | Date |
|---|---|---|
| Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma (NCT03143036) | National University Hospital, Singapore | 2018-05-01 |
Track Relapse and / or Refractory Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.